Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001584759-26-000015

Director sold 13,100 shares at $12.02 ($157,462)

  • Director acquired 3,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-24 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $1.60 $5,600 45,300 D
2026-07-24 Sale : show line 2 in the form 10b5-1 −7,000 $12.02 $84,140 38,300 D
2026-07-24 Sale : show line 3 in the form 10b5-1 −6,100 $12.02 $73,322 206,672 I
Open-market sales · 13,100 sh · avg $12.02 · $157,462

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-24 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −3,500 30,200 D
Loading xslF345X06/form4-07282026_080709.xml…